Novo Nordisk CEO to testify before Senate on weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on August 10, 2022. Christopher Goodney…
health care industry
Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
FTC sues drug brokers for allegedly inflating insulin prices
Federal Trade Commission (FTC) Chair Lina Khan testifies before the House Appropriations Subcommittee in the Rayburn House Office Building on…
Why disputing a medical bill can help reduce your costs
Consumers may feel like their medical bills are inflexible, unyielding, unmovable. But that's not always the case: A new study…
Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
23andMe Independent Directors Resign From Board: Read CEO Memo
Anne Wojcicki, co-founder and CEO of 23andme Inc., speaks during the South by Southwest (SXSW) festival in Austin, Texas, U.S.,…
Roche releases more data on slimming pills and injections
Headquarters of Roche, a multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain. Cristina Arias | Cover | Getty…
FDA authorizes use of Apple's sleep apnea detection feature
Apple Inc. CEO Tim Cook during an event at the Apple Park campus in Cupertino, California, U.S., Monday, Sept. 9,…
Race for radiopharmaceuticals intensifies as drugmakers chase Novartis
Drug makers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough. Bristol-Myers Squibb, AstraZeneca,…
Pfizer's drug for cancer cachexia shows positive results in mid-phase trials
PfizerPfizer's experimental drug for a common, potentially fatal disease that causes cancer patients to lose appetite and weight showed positive…